BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32568442)

  • 21. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
    Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
    Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Liu X; Wan T; Dang S; Wang D; Jiang C; Su Y; Shen M; Tang X; Li X; Li B; Wen L; Feng Q
    Biomed Res Int; 2019; 2019():8146937. PubMed ID: 31871943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
    Kozuka R; Enomoto M; Sato-Matsubara M; Yoshida K; Motoyama H; Hagihara A; Fujii H; Uchida-Kobayashi S; Morikawa H; Tamori A; Kawada N; Murakami Y
    J Gastroenterol Hepatol; 2019 May; 34(5):937-946. PubMed ID: 30160782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.
    Wen J; Song C; Jiang D; Jin T; Dai J; Zhu L; An J; Liu Y; Ma S; Qin N; Liang C; Chen J; Jiang Y; Yang L; Liu J; Liu L; Geng T; Chen C; Jiang J; Chen J; Zhu F; Zhu Y; Yu L; Shen H; Zhai X; Xu J; Hu Z
    Sci Rep; 2015 Nov; 5():16489. PubMed ID: 26568165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.
    Cheng Y; Jiang X; Jin J; Luo X; Chen W; Li Q; Zhang C
    Biochem Genet; 2019 Feb; 57(1):117-128. PubMed ID: 30073579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Du Y; Zhang YW; Pu R; Han X; Hu JP; Zhang HW; Wang HY; Cao GW
    Chin Med J (Engl); 2015 Apr; 128(8):1005-13. PubMed ID: 25881591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX; Li SL; Yao YQ; Li TJ
    Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
    Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
    Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development.
    Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z
    Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families.
    Hsieh AR; Fann CSJ; Lin HC; Tai J; Hsieh SY; Tai DI
    World J Gastroenterol; 2021 Oct; 27(37):6262-6276. PubMed ID: 34712031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Du Y; Han X; Pu R; Xie J; Zhang Y; Cao G
    Front Med; 2014 Jun; 8(2):217-26. PubMed ID: 24748463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma.
    Zhu Q; Li N; Li F; Sang J; Deng H; Han Q; Lv Y; Li C; Liu Z
    Int Immunopharmacol; 2017 Aug; 49():126-131. PubMed ID: 28575727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of HLA-DRB1 gene polymorphisms with hepatocellular carcinoma risk: a meta-analysis.
    Liu L; Guo W; Zhang J
    Minerva Med; 2017 Apr; 108(2):176-184. PubMed ID: 27808488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of human leukocyte antigen-DRB1 alleles with chronic hepatitis B virus infection in the Han Chinese of Northeast China.
    Han Y; Jiang ZY; Jiao LX; Yao C; Lin QF; Ma N; Ju RQ; Yang F; Yu JH; Chen L
    Mol Med Rep; 2012 May; 5(5):1347-51. PubMed ID: 22367481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
    World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
    Zhang QX; Yao YQ; Li SL; Long Q
    Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.